All News #Library
Biotech
Provectus Highlight PV-10 Immune Modulation in Burn Wound Healing
02 Apr 2026 //
GLOBENEWSWIRE
Provectus Bio Positions PV-10 As Unique Vaccine Adjuvant
09 Oct 2025 //
GLOBENEWSWIRE
Provectus Begins Preclinical Study Of Pv-10 For Bladder Cancer
29 Sep 2025 //
GLOBENEWSWIRE
Provectus BioPharma Launches VisiRose for Ophthalmology Treatments
11 Dec 2024 //
GLOBENEWSWIRE
VisiRose Introduces Revolutionary Therapy for Eye Infections
10 Dec 2024 //
ACCESSWIRE
Provectus Announces Presentation of Preclinical PV-10 Vaccine Adjuvant Data
06 Nov 2023 //
GLOBENEWSWIRE

Market Place
Sourcing Support